Literature DB >> 22264793

Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers.

Makoto Yamagishi1, Kazumi Nakano, Ariko Miyake, Tadanori Yamochi, Yayoi Kagami, Akihisa Tsutsumi, Yuka Matsuda, Aiko Sato-Otsubo, Satsuki Muto, Atae Utsunomiya, Kazunari Yamaguchi, Kaoru Uchimaru, Seishi Ogawa, Toshiki Watanabe.   

Abstract

Constitutive NF-κB activation has causative roles in adult T cell leukemia (ATL) caused by HTLV-1 and other cancers. Here, we report a pathway involving Polycomb-mediated miRNA silencing and NF-κB activation. We determine the miRNA signatures and reveal miR-31 loss in primary ATL cells. MiR-31 negatively regulates the noncanonical NF-κB pathway by targeting NF-κB inducing kinase (NIK). Loss of miR-31 therefore triggers oncogenic signaling. In ATL cells, miR-31 level is epigenetically regulated, and aberrant upregulation of Polycomb proteins contribute to miR-31 downregulation in an epigenetic fashion, leading to activation of NF-κB and apoptosis resistance. Furthermore, this emerging circuit operates in other cancers and receptor-initiated NF-κB cascade. Our findings provide a perspective involving the epigenetic program, inflammatory responses, and oncogenic signaling.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264793     DOI: 10.1016/j.ccr.2011.12.015

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  143 in total

1.  microRNA-31 modulates skeletal patterning in the sea urchin embryo.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Development       Date:  2015-09-23       Impact factor: 6.868

Review 2.  Mechanisms of epigenetic deregulation in lymphoid neoplasms.

Authors:  Yanwen Jiang; Katerina Hatzi; Rita Shaknovich
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

3.  MicroRNA-31 is a potential biomarker for screening B-lymphoblastic leukemia in children.

Authors:  Yan Zhang; Xin Li; Liping Bai; Li Li; Danhong Li; Xue Ding; Bo Wang; Chengwei Li
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

4.  Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.

Authors:  Katia Ruggero; Alessandro Guffanti; Alberto Corradin; Varun Kumar Sharma; Gianluca De Bellis; Giorgio Corti; Angela Grassi; Paola Zanovello; Vincenzo Bronte; Vincenzo Ciminale; Donna M D'Agostino
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 5.  Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.

Authors:  Sho Ikeda; Hiroyuki Tagawa
Journal:  Int J Hematol       Date:  2014-02-25       Impact factor: 2.490

6.  Involvement of double-stranded RNA-dependent protein kinase and antisense viral RNA in the constitutive NFκB activation in adult T-cell leukemia/lymphoma cells.

Authors:  S Kinpara; S Ito; T Takahata; Y Saitoh; A Hasegawa; M Kijiyama; A Utsunomiya; M Masuda; Y Miyazaki; M Matsuoka; M Nakamura; S Yamaoka; T Masuda; M Kannagi
Journal:  Leukemia       Date:  2014-01-08       Impact factor: 11.528

Review 7.  Polycomb genes, miRNA, and their deregulation in B-cell malignancies.

Authors:  Gang Greg Wang; Kyle D Konze; Jianguo Tao
Journal:  Blood       Date:  2015-01-07       Impact factor: 22.113

8.  Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.

Authors:  Priya Samuel; Ryan Charles Pink; Daniel Paul Caley; James Michael Stevenson Currie; Susan Ann Brooks; David Raul Francisco Carter
Journal:  Tumour Biol       Date:  2015-09-19

Review 9.  Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Authors:  Noriaki Yoshida; Dai Chihara
Journal:  Curr Treat Options Oncol       Date:  2015-02

10.  A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.

Authors:  Sanhong Liu; Xiaohua Sun; Mingliang Wang; Yingyong Hou; Yu Zhan; Yuhang Jiang; Zhanjie Liu; Xinwei Cao; Pengfei Chen; Zhi Liu; Xi Chen; Yu Tao; Chen Xu; Jie Mao; Chunyan Cheng; Cuifeng Li; Yiming Hu; Lunshan Wang; Y Eugene Chin; Yufang Shi; Ulrich Siebenlist; Xiaoren Zhang
Journal:  Gastroenterology       Date:  2014-06-12       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.